abstract |
The present invention provides compositions comprising an effective amount of an agent that inhibits a BET protein (e.g., Brd2, Brd3, Brd4), and the use of such compositions to treat or prevent metabolic syndrome, obesity , type II diabetes, insulin resistance and related disorders characterized by unwanted changes in metabolism or fat accumulation. |